Structures by: Benzeid H.
Total: 9
(<i>Z</i>)-3-(4-Methylbenzylidene)-4-oxopentanoic acid
C13H14O3
IUCrData (2016) 1, 12 x162003
a=9.2491(5)Å b=18.1423(10)Å c=14.3719(7)Å
α=90° β=96.610(3)° γ=90°
1-Ethyl-3-methylquinoxalin-2(1<i>H</i>)-one
C11H12N2O
Acta Crystallographica Section E (2008) 64, 11 o2234
a=7.4101(6)Å b=9.1405(8)Å c=14.2960(12)Å
α=84.976(7)° β=78.717(7)° γ=88.137(7)°
3-Methyl-1-propargylquinoxalin-2(1<i>H</i>)-one
C12H10N2O
Acta Crystallographica Section E (2009) 65, 9 o2196
a=21.1240(10)Å b=4.3709(2)Å c=22.2460(10)Å
α=90.00° β=105.354(6)° γ=90.00°
\ 10-Allyl-2,3-dihydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,\ 11(10<i>H</i>,11a<i>H</i>)-dione
C15H16N2O2
Acta Crystallographica Section E (2009) 65, 10 o2322
a=7.09880(10)Å b=11.7166(2)Å c=15.6592(3)Å
α=90.00° β=90.00° γ=90.00°
1-Methyl-3-phenylquinoxalin-2(1<i>H</i>)-one
C15H12N2O
Acta Crystallographica Section E (2009) 65, 10 o2323
a=16.3919(5)Å b=7.0775(2)Å c=20.0214(6)Å
α=90.00° β=95.434(2)° γ=90.00°
1-Benzyl-3-phenylquinoxalin-2(1<i>H</i>)-one
C21H16N2O
Acta Crystallographica Section E (2009) 65, 11 o2685
a=5.4776(2)Å b=12.7015(3)Å c=12.7469(4)Å
α=62.260(2)° β=89.963(2)° γ=87.845(2)°
10,10'-Methylenebis[2,3-dihydro-1<i>H</i>- benzo[<i>e</i>]pyrrolo[1,2-<i>a</i>][1,4]diazepine- 5,11(10<i>H</i>,11a<i>H</i>)-dione] dihydrate
C25H24N4O4,2(H2O)
Acta Crystallographica Section E (2009) 65, 11 o2684
a=11.9901(2)Å b=11.9901Å c=13.6054(2)Å
α=90° β=90° γ=120°
1-Acetyl-4-phenyl-5a,6,7,8,9,9a-hexahydro-5<i>H</i>- 1,5-benzodiazepin-2(1<i>H</i>)-one
C17H20N2O2
Acta Crystallographica Section E (2009) 65, 11 o2657
a=9.6794(2)Å b=14.0095(3)Å c=11.2832(2)Å
α=90° β=98.0530(10)° γ=90°
1-allyl-3-phenylquinoxalin-2(1<i>H</i>)-one
C17H14N2O
Acta Crystallographica Section E (2011) 67, 11 o2990
a=15.123(2)Å b=7.0390(10)Å c=26.405(3)Å
α=90.00° β=95.250(10)° γ=90.00°